ArticleThe Journal of clinical investigation2018

Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.

Nathaniel W Mabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.